{"id":"W3129416935","doi":"10.1016/j.jaad.2021.02.057","title":"Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"AbbVie","keywords":"Medicine; Discontinuation; Etanercept; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Certolizumab pegol; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001190474,0.0005253632,0.01535227,0.0003369189,0.0001215343,0.000006686639,0.0008518159,0.000648173,0.00003247218],"category_scores_gemma":[0.000307967,0.0002793094,0.003019553,0.0007348305,0.0008887809,0.00006331328,0.0004232601,0.0005265625,7.941172e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003097541,"about_ca_system_score_gemma":0.0003402794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004061923,"about_ca_topic_score_gemma":0.00002561374,"domain_scores_codex":[0.9923796,0.003168103,0.003490539,0.0005439816,0.00008627067,0.0003314938],"domain_scores_gemma":[0.9851522,0.00454584,0.009543741,0.0005247785,0.0001618463,0.00007156805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03338658,0.0007616983,0.0008541209,0.0005302168,0.6871114,0.000007804329,0.000222512,0.0001714349,0.00001046407,0.0003965129,0.001623004,0.2749243],"study_design_scores_gemma":[0.01546503,0.002561538,0.0005203603,0.0003597471,0.7534277,0.0008189548,0.0002048817,0.00004550526,0.0001330361,0.0001351344,0.2259214,0.0004066736],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01819449,0.9742901,0.00009620363,0.0003879541,0.0003045885,0.00125616,0.005457337,0.000003856603,0.000009282495],"genre_scores_gemma":[0.007489135,0.9891336,0.002778418,0.00007111825,0.00008287818,0.00004891251,0.0003111035,0.00002034599,0.00006446377],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2745176,"threshold_uncertainty_score":0.9999659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3244600785064637,"score_gpt":0.455488217822944,"score_spread":0.1310281393164802,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}